Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine.
Journal
Clinical and molecular allergy : CMA
ISSN: 1476-7961
Titre abrégé: Clin Mol Allergy
Pays: England
ID NLM: 101152195
Informations de publication
Date de publication:
12 Dec 2022
12 Dec 2022
Historique:
received:
01
06
2022
accepted:
05
10
2022
entrez:
12
12
2022
pubmed:
13
12
2022
medline:
13
12
2022
Statut:
epublish
Résumé
Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure. A vast array of possible side effects associated with administration of different anti-SARS-CoV-2 vaccines have been reported in literature since the beginning of the COVID-19 pandemic, but only few times SDRIFE-like eruptions have been described in this context. We discuss here a case of SDRIFE-like eruption following the second dose of Oxford-Astrazeneca Vaxzevria vaccine.
Identifiants
pubmed: 36503530
doi: 10.1186/s12948-022-00179-8
pii: 10.1186/s12948-022-00179-8
pmc: PMC9742018
doi:
Types de publication
Letter
Langues
eng
Pagination
13Informations de copyright
© 2022. The Author(s).
Références
Contact Dermatitis. 2022 Jul;87(1):91-93
pubmed: 35243643
Int J Dermatol. 2017 May;56(5):571-572
pubmed: 28217835
Clin Pharmacol Ther. 1981 Aug;30(2):239-45
pubmed: 7249508
Dermatol Online J. 2009 Aug 15;15(8):3
pubmed: 19891911
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180
pubmed: 34661927
J Eur Acad Dermatol Venereol. 2021 Oct;35(10):e634-e635
pubmed: 34138472
Dermatol Ther. 2022 Jul;35(7):e15546
pubmed: 35485220
J Dermatol Case Rep. 2015 Mar 31;9(1):12-4
pubmed: 25932057
Dermatol Clin. 2021 Oct;39(4):653-673
pubmed: 34556254
J Clin Med. 2021 Nov 16;10(22):
pubmed: 34830627
JAAD Case Rep. 2015 May 25;1(3):147-9
pubmed: 27051713
Am J Clin Dermatol. 2011 Jun 1;12(3):171-80
pubmed: 21469762
JAAD Case Rep. 2021 Dec;18:57-60
pubmed: 34722840
Contact Dermatitis. 2018 Dec;79(6):378-380
pubmed: 30062790
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e597-e599
pubmed: 35344627
Clin Exp Dermatol. 2022 Jan;47(1):175-176
pubmed: 34399001
Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):313-8
pubmed: 21659857